Development code · Small Molecule
OPC-34712
OPC-34712 is a development code for Brexpiprazole, developed by Otsuka Pharmaceutical Co., Ltd..
- Status
- Filed (NDA) for Post-traumatic stress disorder
- Mechanism
- D2 Partial agonist
- Developer
- Otsuka Pharmaceutical Co., Ltd.
Programs
- Brexpiprazole for Post-traumatic stress disorderFiled (NDA)Discontinued
Also known as
- Rexulti
- Rxulti
- brexpiprazole
- 913611-97-9
- 7-[4-[4-(1-benzothiophen-4-yl)piperazin-1-yl]butoxy]-1H-quinolin-2-one